Share on facebook Share on Twitter Share on Google Plus Share This
Back to Results

David van Klaveren, PhD, MSc


Research Interests Predictive modeling, model validation
Training + Education Erasmus University Medical Center, Rotterdam
Gender Male
Language(s) Dutch
Accepted Insurances View Accepted Insurances at Tufts MC + Floating Hospital

Honors + Awards

2015, Journal of Clinical Epidemiology Young Investigator Award
2013, Erasmus University Medical Center, Department of Public Health Best Debut Publication Award

Publications + National Presentations

1. Upshaw JN, Konstam MA, van Klaveren D, Noubary F, Huggins GS, Kent DM. Multistate Model to Predict Heart Failure Hospitalizations and All-Cause Mortality in Outpatients With Heart Failure With Reduced Ejection Fraction: Model Derivation and External Validation. Circ Heart Fail. 2016 Aug;9(8). pii: e003146.

2. Austin PC, van Klaveren D, Vergouwe Y, Nieboer D, Lee DS, Steyerberg EW. Geographic and temporal validity of prediction models: different approaches were useful to examine model performance. J Clin Epidemiol. 2016 Jun 2. pii: S0895-4356(16)30140-8.

3. van Klaveren D, Gönen M, Steyerberg EW, Vergouwe Y. A new concordance measure for risk prediction models in external validation settings. Stat Med. 2016 Oct 15;35(23):4136-52.

4. van Klaveren D*, Götz HM*, Op de Coul EL, Steyerberg EW, Vergouwe Y. Prediction of Chlamydia trachomatis infection to facilitate selective screening on population and individual level: a cross-sectional study of a population-based screening programme. Sex Transm Infect. 2016 Sep;92(6):433-40.

5. van den Hoven I, van Klaveren D, Voogd AC, Vergouwe Y, Tjan-Heijnen V, Roumen RM. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients. Clin Breast Cancer. 2016 Apr;16(2):123-30.

6. Osnabrugge RL, Magnuson EA, Serruys PW, Campos CM, Wang K, van Klaveren D, Farooq V, Abdallah MS, Li H, Vilain KA, Steyerberg EW, Morice MC, Dawkins KD, Mohr FW, Kappetein AP, Cohen DJ; SYNTAX trial investigators. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective. Heart. 2015 Dec;101(24):1980-8.

7. van Klaveren D, Vergouwe Y, Farooq V, Serruys PW, Steyerberg EW. Estimates of absolute treatment benefit for individual patients required careful modeling of statistical interactions. J Clin Epidemiol. 2015 Nov;68(11):1366-74.

8. Campos CM*, van Klaveren D*, Farooq V, Simonton CA, Kappetein AP, Sabik JF 3rd, Steyerberg EW, Stone GW, Serruys PW; EXCEL Trial Investigators. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II. Eur Heart J. 2015 May 21;36(20):1231-41.

9. van Klaveren D, Steyerberg EW, Perel P, Vergouwe Y. Assessing discriminative ability of risk models in clustered data. BMC Med Res Methodol. 2014 Jan 15;14:5.

10. Farooq V*, van Klaveren D*, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, Kappetein AP, Colombo A, Holmes DR Jr, Mack M, Feldman T, Morice MC, Ståhle E, Onuma Y, Morel MA, Garcia-Garcia HM, van Es GA, Dawkins KD, Mohr FW, Serruys PW. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013 Feb 23;381(9867):639-50.


David van Klaveren, PhD, MSc was born on July 31, 1973 in Rotterdam, The Netherlands. In 1991 he graduated from secondary school (Christelijke Scholengemeenschap Walcheren, Middelburg) and started studying Technical Mathematics at Delft University of Technology. In 1997 he obtained his master’s degree with a thesis on quantitative aspects of risk analysis.

After his graduation, Dr. van Klaveren established a Risk Analysis Section within Strukton, a large infrastructural building contractor in Maarssen. He switched to the insurance business in 1998 to work as an actuarial consultant for Posthuma Partners in The Hague. In 2003 he started working for the Dutch branch of the global insurance company Allianz in Rotterdam, first as a senior actuary, and later on as head of the Pricing Department. In 2009 he completed, cum laude, the Actuarial Sciences Master’s program at the University of Amsterdam.

In 2011. Dr. van Klaveren changed his career to become a researcher in medical decision making at the Department of Public Health of Erasmus University Medical Center in Rotterdam. In 2015, he received the Young Investigator Award from the Journal of Clinical Epidemiology. Since 2015, he is a research associate / visiting scholar at the Predictive Analytics and Comparative Effectiveness Center of Tufts Medical Center in Boston, and an associate editor of BMC Medical Informatics and Decision Making. He obtained a cum laude PhD degree in January 2017 and currently holds an Assistant Professor position at the Medical Statistics department of Leiden University Medical Center.

In his spare time, Dr. van Klaveren enjoys running (Rotterdam marathon 2013 and 2014), Korfball (played in the Dutch top league for many years as captain of KV Fortuna Delft, played for 3 years in Holland U23, trained and coached various teams), reading non-fiction (history) and international literature books and mountain hiking and skiing.

Professional Memberships

Associate Editor for BMC Medical Informatics and Decision Making
Statistical consulting at Leiden University Medical Center and Erasmus University Medical Center Rotterdam
Peer reviewer for international Journals: Journal of Clinical Epidemiology, BMC Medical Research Methodology, EuroIntervention